top of page
BreStem's objective is to develop and bring to market the most advanced product based on the transformative potential of cellular and acellular therapy utilizing Lung Spheroid Cells as a treatment option for individuals living with pulmonary fibrosis. Many lung diseases such as idiopathic pulmonary fibrosis (IPF) are chronic and ultimately fatal, with no current cure. BreStem's pipeline of revolutionary products provides any patients with the hope of a better life in the face of limited options and no effective therapies.
bottom of page